All In Biotech

Drug Trial Radar · NCT05250063

Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)

A Multicenter, Open-Label, Phase 2 Study to Evaluate Growth and Safety of LUM-201 Following 12 Months of Daily rhGH Treatment in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed the LUM-201-01 Trial

Last checked: Nov 19, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

15

Actual

Start

Feb 18, 2022

Primary completion

Jan 22, 2025

Study completion Jan 22, 2025

Sponsor

Lead sponsor
Lumos PharmaIndustry
Sponsor type
Industry
First posted
Feb 22, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 3 years, up to 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-national trial. The goals of the trial are to study the growth response to LUM-201 administration in children with idiopathic growth hormone deficiency (GHD) previously treated with daily rhGH for 12 months in the LUM-201-01 trial.

Conditions

  • Growth Hormone Deficiency

Interventions

  • LUM-201Drug

    Administered orally once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized Height Velocity (AHV) Measured as Standing Height With StadiometerTime frame: Day 1 to Month 12

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Rady Children's Hospital

    San Diego, California

  • Children's National Hospital

    Washington D.C., District of Columbia

  • Indiana University School of Medicine

    Indianapolis, Indiana

  • M Health, Fairview Pediatric Specialty Clinics- Discovery Clinic

    Minneapolis, Minnesota

  • The Children's Mercy Hospital

    Kansas City, Missouri

  • Nationwide Children's Hospital

    Columbus, Ohio

  • University of Virginia Health System

    Charlottesville, Virginia

  • Klinika Endokrynologii i Chorob Metabolicznych, Instytut Centrum Zdrowia Matki Polki

    Lodz, Poland

  • Sonomed - Centrum Medyczne

    Szczecin, Poland

  • Klinika Endokrynologii i Diabetologii, Instytut "Pomnik Centrum Zdrowia Dziecka

    Warsaw, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.